Global Stem Cell Therapy Market Report and Forecast 2023-2031

Report
147 Pages
May 2023
Region: Global
Expert Market Research
ID: 5798013

The global stem cell therapy market value was USD 246 million in 2022, driven by the increasing demand for regenerative therapies structure across the globe. The market size is anticipated to grow at a CAGR of 18.5% during the forecast period of 2023-2031 to achieve a value of USD 1133.4 million by 2031.

Stem Cell Therapy Introduction

Stem cells are unique, undifferentiated cells with the ability to differentiate into specialized cell types and self-renew to produce more stem cells. This extraordinary feature of stem cells has made them a subject of immense interest in regenerative medicine, as they hold the potential to repair or replace damaged or diseased tissues and organs. Stem cell research has led to ground-breaking advancements in the treatment of various conditions, including spinal cord injuries, Alzheimer's disease, Parkinson's disease, and cancer, among others.

Stem Cell Therapy Market Scenario

The global stem cell market has experienced significant growth in recent years, driven by factors such as the rising prevalence of chronic diseases, an aging population, and the increasing demand for regenerative therapies. The market has also been fueled by ongoing advancements in stem cell research, the development of novel stem cell-based therapies, and a supportive regulatory environment. Furthermore, the growing awareness of the potential benefits of stem cell therapies and increasing investments in research and development have contributed to the market's expansion.

North America: The largest market for stem cells, driven by factors such as advanced healthcare infrastructure, a strong focus on research and development, and the high prevalence of chronic diseases.

Europe: The second-largest market, with increasing demand for stem cell therapies due to a growing awareness of their potential benefits and a supportive regulatory framework.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.

Stem Cell Therapy Market Segmentations

Market Breakup by Treatment

Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy
Syngeneic Stem Cell Therapy

Market Breakup by Product Type

Adult Stem Cell

Hematopoietic Stem Cells (Blood Stem Cells)
Mesenchymal Stem Cells
Neural Stem Cells
Epithelial/Skin Stem Cells
Other Adult Stem Cells
Human Embryonic Cell
Pluripotent Stem Cell
Others

Market Breakup by Application

Musculoskeletal Disorders
Neurological Disorders
Oncology Disorders
Cardiovascular Disorders
Cancers
Wounds and Injuries
Others

Market Breakup by Technology

Cell Acquisition

Bone Marrow Harvest
Umbilical Blood Cord
Apheresis

Cell Production

Therapeutic Cloning
In Vitro Fertilization
Cell Culture
Isolation
Cryopreservation
Expansion And Sub-Culture

Market Breakup by End User

Pharmaceutical And Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes

Market Breakup by Region

North America

United States of America
Canada

Europe

United Kingdom
Germany
France
Italy
Others

Asia Pacific

China
Japan
India
ASEAN
Australia
Others

Latin America

Brazil
Argentina
Mexico
Others

Middle East and Africa

Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Key Trends in the Stem Cell Therapy Market

Some key trends of the market are as follows:

Increasing demand for regenerative therapies: The growing prevalence of chronic diseases and an aging population have resulted in a higher demand for regenerative therapies, driving the growth of the stem cell market
Advancements in stem cell research: Ongoing research and development efforts have led to the discovery of novel stem cell-based therapies and techniques, fueling market growth
Supportive regulatory environment: Regulatory bodies worldwide are increasingly recognizing the potential benefits of stem cell therapies, leading to a more favorable environment for the development and commercialization of these treatments

Stem Cell Therapy Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Thermo Fisher Scientific
Bayer AG
Stem Cell Therapys International Group, Ltd
Takeda Pharmaceutical Company Limited
MEDIPOST Co., Ltd
JCR Pharmaceuticals Co., Ltd
Astellas Pharma Inc
Mesoblast Ltd
Novadip Biosciences S.A
Nuvasive Inc
Molecular Devices Corporation
Amgen Inc
GENEA BIOCELLS
WAISMAN BIOMANUFACTURING
TIGENIX

1 Preface

1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology

2 Executive Summary

3 Global Stem Cell Therapy Market Overview

3.1 Global Stem Cell Therapy Market Historical Value (2016-2022)
3.2 Global Stem Cell Therapy Market Forecast Value (2023-2031)

4 Global Stem Cell Therapy Market Landscape

4.1 Global Stem Cell Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stem Cell Therapy Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Treatment
4.2.3 Analysis by Applications

5 Global Stem Cell Therapy Market Dynamics

5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis

6 Global Stem Cell Therapy Market Segmentation

6.1 Global Stem Cell Therapy Market by Treatment
6.1.1 Market Overview
6.1.2 Allogeneic Stem Cell Therapy
6.1.3 Autologous Stem Cell Therapy
6.1.4 Syngeneic Stem Cell Therapy
6.2 Global Stem Cell Therapy Market by Product Type
6.2.1 Market Overview
6.2.2 Adult Stem Cell
6.2.2.1 Hematopoietic Stem Cells (Blood Stem Cells)
6.2.2.2 Mesenchymal Stem Cells
6.2.2.3 Neural Stem Cells
6.2.2.4 Epithelial/Skin Stem Cells
6.2.2.5 Other Adult Stem Cells
6.2.3 Human Embryonic Cell
6.2.4 Pluripotent Stem Cell
6.2.5 Others
6.3 Global Stem Cell Therapy Market by Application
6.3.1 Market Overview
6.3.2 Musculoskeletal Disorders
6.3.3 Neurological Disorders
6.3.4 Oncology Disorders
6.3.5 Cardiovascular Disorders
6.3.6 Cancers
6.3.7 Wounds and Injuries
6.3.8 Others
6.4 Global Stem Cell Therapy Market by Technology
6.4.1 Market Overview
6.4.2 Cell Acquisition
6.4.2.1 Bone Marrow Harvest
6.4.2.2 Umbilical Blood Cord
6.4.2.3 Apheresis
6.4.3 Cell Production
6.4.3.1 Therapeutic Cloning
6.4.3.2 In Vitro Fertilization
6.4.3.3 Cell Culture
6.4.3.4 Isolation
6.4.4 Cryopreservation
6.4.5 Expansion And Sub-Culture
6.5 Global Stem Cell Therapy Market by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical And Biotechnology Companies
6.5.3 Hospitals & Cell Banks
6.5.4 Academic & Research Institutes
6.6 Global Stem Cell Therapy Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa

7 North America Stem Cell Therapy Market

7.1 Market Share by Country
7.2 United States of America
7.3 Canada

8 Europe Stem Cell Therapy Market

8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others

9 Asia Pacific Stem Cell Therapy Market

9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others

10 Latin America Stem Cell Therapy Market

10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others

11 Middle East and Africa Stem Cell Therapy Market

11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others

12 Patent Analysis

12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players

13 Grants Analysis

13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization

14 Clinical Trials Analysis

14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography

15 Funding Analysis

15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography

16 Partnership and Collaborations Analysis

16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography

17 Regulatory Framework

17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others

18 Supplier Landscape

18.1 Thermo Fisher Scientific
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bayer AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Stem Cell Therapys International Group, Ltd.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Takeda Pharmaceutical Company Limited
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 MEDIPOST Co., Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 JCR Pharmaceuticals Co., Ltd.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Astellas Pharma Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Mesoblast Ltd.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Novadip Biosciences S.A.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Nuvasive Inc
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Molecular Devices Corporation
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Amgen Inc
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 GENEA BIOCELLS
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 WAISMAN BIOMANUFACTURING
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 TIGENIX
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications

19 Global Stem Cell Therapy Market- Distribution Model (Additional Insight)

19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment

20 Key Opinion Leaders (KOL) Insights (Additional Insight)

21 Company Competitiveness Analysis (Additional Insight)

21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies

22 Payment Methods (Additional Insight)

22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket

Companies Mentioned

Thermo Fisher Scientific
Bayer AG
Stem Cell Therapys International Group, Ltd.
Takeda Pharmaceutical Company Limited
Medipost Co. Ltd.
Jcr Pharmaceuticals Co. Ltd.
Astellas Pharma Inc.
Mesoblast Ltd.
Novadip Biosciences S.A.
Nuvasive Inc
Molecular Devices Corporation
Amgen Inc
Genea Biocells
Waisman Biomanufacturing
Tigenix

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	147
Published	May 2023
Forecast Period	2023 - 2031
Estimated Market Value ( USD ) in 2023	$ 291.5 Million
Forecasted Market Value ( USD ) by 2031	$ 1133.4 Million
Compound Annual Growth Rate	18.5%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5790EUR$5,999USD£4,967GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7721EUR$7,999USD£6,623GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9651EUR$9,999USD£8,279GBP